Mesoblast (ASX:MSB) EV-to-EBITDA: (As of Jul. 18, 2026)

Mesoblast  (ASX:MSB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Mesoblast's PE Ratio (TTM) for today is calculated as:

Mesoblast's share price for today is A$2.44.
Mesoblast's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was A$0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Mesoblast EV-to-EBITDA Related Terms

The historical data trend for Mesoblast's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mesoblast EV-to-EBITDA Chart

Mesoblast Annual Data
	Trend	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23	Jun24	Jun25
EV-to-EBITDA		Get a 7-Day Free Trial					-11.22	-4.38	-10.62	-11.95	-16.81

Mesoblast Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EV-to-EBITDA	Get a 7-Day Free Trial															0.00	-16.81	0.00	0.00	0.00

ASX:MSB vs VRTX, REGN, ALNY: EV-to-EBITDA Comparison

For the Biotechnology subindustry, Mesoblast's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mesoblast EV-to-EBITDA vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mesoblast's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Mesoblast's EV-to-EBITDA falls into.

Mesoblast EV-to-EBITDA Calculation

Mesoblast's EV-to-EBITDA for today is calculated as:

Mesoblast's current Enterprise Value is A$3,168.07 Mil.
Mesoblast's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mesoblast Business Description